Literature DB >> 15627794

Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis.

Arndt T Petermann1, Jeffrey Pippin, Ron Krofft, Mary Blonski, Sian Griffin, Raghu Durvasula, Stuart J Shankland.   

Abstract

BACKGROUND: A decrease in podocyte number contributes to the development of glomerulosclerosis in diabetic nephropathy. Although podocytes have been detected in the urine in certain glomerular diseases, their viability is poorly understood.
METHODS: Diabetes was induced in rats with streptozotocin. Urine was collected from control rats (given citrate), and rats with diabetic nephropathy, and cells obtained by centrifugation were resuspended in tissue culture media, and seeded onto collagen-coated tissue culture plates. Cells were grown under standard cell culture conditions ex vivo. Cell number was measured, the cell type in the urine was identified by immunostaining with specific antibodies, and morphology was assessed by light and electron microscopy.
RESULTS: Within 24 h, cells obtained from the urine of diabetic rats attached to tissue culture plates ex vivo. Cells were not detected in the urine from control rats. All cells from diabetic rats stained positive for the podocyte-specific proteins synaptopodin, nephrin, podocin and Glepp-1 and negative for mesangial (OX-7), tubular (Tamm-Horsfall protein) and endothelial (RECA) cell antigens. The cell number increased daily, which is consistent with cell growth ex vivo.
CONCLUSIONS: Rats with diabetic nephropathy shed podocytes into the urine that attach and grow ex vivo. These results are consistent with the detachment of viable podocytes in diabetes and add new perspectives into our understanding of development of glomerulosclerosis in diabetes mellitus. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2004        PMID: 15627794     DOI: 10.1159/000081555

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  45 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

Review 2.  Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

Authors:  Caroline B Marshall
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

3.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.

Authors:  Larysa Wickman; Farsad Afshinnia; Su Q Wang; Yan Yang; Fei Wang; Mahboob Chowdhury; Delia Graham; Jennifer Hawkins; Ryuzoh Nishizono; Marie Tanzer; Jocelyn Wiggins; Guillermo A Escobar; Bradley Rovin; Peter Song; Debbie Gipson; David Kershaw; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

Review 4.  Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.

Authors:  Frank C Brosius; Richard J Coward
Journal:  Adv Chronic Kidney Dis       Date:  2014-05       Impact factor: 3.620

5.  Activation of NFAT signaling in podocytes causes glomerulosclerosis.

Authors:  Yinqiu Wang; George Jarad; Piyush Tripathi; Minggui Pan; Jeanette Cunningham; Daniel R Martin; Helen Liapis; Jeffrey H Miner; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

Review 6.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

Review 7.  Therapeutic targets in focal and segmental glomerulosclerosis.

Authors:  Peter J Lavin; Rasheed Gbadegesin; Tirupapuliyur V Damodaran; Michelle P Winn
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

Review 8.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15

9.  Urine podocyte mRNAs mark progression of renal disease.

Authors:  Yuji Sato; Bryan L Wharram; Sang Koo Lee; Larysa Wickman; Meera Goyal; Madhusudan Venkatareddy; Jai Won Chang; Jocelyn E Wiggins; Chrysta Lienczewski; Matthias Kretzler; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.

Authors:  Kimberly Reidy; Katalin Susztak
Journal:  Am J Kidney Dis       Date:  2009-10       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.